Related Experiment Videos
Alloreactivity studied with mutants of HLA-A2
J Santos-Aguado1, M A Crimmins, S J Mentzer
1Division of Tumor Virology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115.
Summary
This study describes a model for alloreactivity, explaining how T-cell receptors recognize foreign HLA-A2.1 molecules by accommodating minor amino acid differences, a phenomenon known as cross-recognition.
Area of Science:
- Immunology
- Molecular Biology
- Structural Biology
Background:
- Major Histocompatibility Complex (MHC) molecules present peptides to T-cell receptors (TCRs).
- Alloreactivity, where TCRs recognize foreign MHC molecules, is a key challenge in transplantation.
- The structural basis of alloreactivity and TCR cross-recognition remains incompletely understood.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying alloreactivity.
- To propose a model explaining T-cell receptor recognition of allogeneic MHC molecules.
Main Methods:
- Analysis of the crystal structure of HLA-A2.1.
- Characterization of T-cell receptor recognition of mutant HLA-A2.1 molecules using cytotoxic T lymphocyte clones.
Main Results:
- A model for alloreactivity based on TCR accommodation of amino acid differences in allogeneic MHC molecules (cross-recognition).
- Alloreactivity is attributed to unusual self-peptides presented by allogeneic MHC molecules, escaping negative thymic selection.
Conclusions:
- Cross-recognition of allogeneic MHC molecules by self-restricted TCRs is a primary mechanism of alloreactivity.
- The presence of unique self-peptides within the allogeneic MHC binding site contributes to alloreactive responses.